9.4LGDec 10, 2025
Mitigating Exposure Bias in Risk-Aware Time Series Forecasting with Soft TokensAlireza Namazi, Amirreza Dolatpour Fathkouhi, Heman Shakeri
Autoregressive forecasting is central to predictive control in diabetes and hemodynamic management, where different operating zones carry different clinical risks. Standard models trained with teacher forcing suffer from exposure bias, yielding unstable multi-step forecasts for closed-loop use. We introduce Soft-Token Trajectory Forecasting (SoTra), which propagates continuous probability distributions (``soft tokens'') to mitigate exposure bias and learn calibrated, uncertainty-aware trajectories. A risk-aware decoding module then minimizes expected clinical harm. In glucose forecasting, SoTra reduces average zone-based risk by 18\%; in blood-pressure forecasting, it lowers effective clinical risk by approximately 15\%. These improvements support its use in safety-critical predictive control.
5.1LGMay 1
Deep Kernel Learning for Stratifying Glaucoma TrajectoriesBruce Rushing, Angela Danquah, Alireza Namazi et al.
Effectively stratifying patient risk in chronic diseases like glaucoma is a major clinical challenge. Clinicians need tools to identify patients at high risk of progression from sparse and irregularly-sampled electronic health records (EHRs). We propose a novel deep kernel learning (DKL) architecture that leverages a Gaussian Process (GP) backend. The GP's kernel is defined by a transformer-based feature extractor applied to clinical-BERT embeddings to model glaucoma patient trajectories from multimodal EHR data. Our method successfully identifies three clinically distinct patient subgroups. Crucially, the model learns to decouple disease progression from current severity, identifying a high-risk group with a worsening trajectory despite having better average visual acuity than a second, stably poor group. This reveals that the model learns to identify progression risk rather than just the current disease state. This ability to stratify patients based on their risk trajectory progression offers a powerful tool for clinical decision support, enabling targeted interventions for high-risk individuals and improving the management of glaucoma care.